Cardinal Health, Inc. (CAH)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $bn | 153 | 162 | 181 | 205 | 227 | 223 | 254 | 254 |
| Operating profit | $bn | 3 | 3 | ||||||
| Net profit | $bn | -4 | 1 | -1 | 0 | 1 | 2 | 2 | 2 |
| EPS reported | $ | 7.23 | 7.23 | ||||||
| Operating cashflow per share | $ | 21.92 | 21.92 | ||||||
| Capex per share | $ | 2.75 | 2.75 | ||||||
| FCF per share | $ | 19.17 | 19.17 | ||||||
| Free cash flow | $bn | 5 | 5 | ||||||
| Net debt | $bn | 4 | 5 | ||||||
| Book value equity | $bn | -3 | -3 | ||||||
| Book value per share | $ | -12.16 | -12.16 | ||||||
| Number of shares | m | 237 | 237 | ||||||
| DPS (TTM paid) | $ | 2.05 | 2.56 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 17.56 | 30.46 | ||||||
| P/B LTM | x | -19.45 | -14.04 | ||||||
| P/S LTM | x | 0.19 | 0.16 | ||||||
| P/FCF LTM | x | 12.39 | 8.95 | ||||||
| EV/EBITDA LTM | x | 12.06 | 13.21 | ||||||
| EV/Sales LTM | x | 0.23 | 0.25 | ||||||
| Earnings Yield LTM | % | +6.84% | +3.28% | ||||||
| FCF Yield | % | +8.07% | +11.18% | ||||||
| Quality | |||||||||
| ROE | % | -59.45% | -59.73% | ||||||
| ROIC | % | +13.24% | +13.24% | ||||||
| Operating margin | % | +1.03% | +1.03% | ||||||
| Gross margin | % | +3.84% | +3.84% | ||||||
| FCF/Sales | % | +1.78% | +1.78% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +12.09% | +109.57% | ||||||
| Sales Growth YoY | % | +14.23% | +12.09% | ||||||
| Net Income Growth YoY | % | +9.80% | +101.17% | ||||||
| FCF Growth | % | +144.59% | +39.19% | ||||||
| Operating Profit Growth | % | +14.86% | +110.22% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +0.88% | +0.83% | ||||||
| Dividend Growth | % | +1.00% | +69.58% | ||||||
| Payout Ratio | % | +28.65% | +28.62% | ||||||
| FCF/Debt | x | 0.45 | 0.45 | ||||||
| Net Debt/EBITDA | x | 1.46 | 1.46 | ||||||
| EBIT/Net interest | x | 7.51 | 7.51 | ||||||
| Net debt/market cap | % | +15.52% | +15.03% | ||||||
| Net debt/Equity | x | -1.33 | -1.77 | ||||||
| Gross debt/equity | x | -3.45 | -3.45 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free